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Objectives: This study consisted of two parts. One part was to analyze the survival rates of adenoid cystic
carcinoma (ACC) in Chinese and explain the difference between our data and the literature. The other was to
analyze the relationship between the expression of CD117 and the histological grade and the prognosis.
Methods: A retrospective study of 80 ACC patients was performed. Clinical data were collected, and p63,
CD117 were detected by immunohistochemical staining.
Results: Eighty patients received follow-ups 3 to 216 months after initial diagnosis. ACC occurred in the
lacrimal gland (26.3%, n = 21), nasal cavity and parasinus (33.8%, n = 27) and other sites (40.0%, n = 33). The 5-year
and 10-year survival rates were 66.41% and 10.16%, respectively. Over expression of CD117 was detected in
p63-negative cells in 94.3% of cases and in p63-positive cells in 45.8%. The expression of CD117 in p63-positive cells
was significantly associated with the histological grade (P<0.001) and prognosis (P = 0.037) in patients in the
advanced stage.
Conclusions: ACC had a good 5-year survival but poor 10-year survival in Chinese, which differed from the
occidental data. More p63+/CD117+ cells were associated with a higher histological grade and poorer outcome.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1701457278762097
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Adenoid cystic carcinoma (ACC), first described in the
1850 s, is an uncommon malignant tumor that accounts
for less than 5 percent of head-and-neck cancers [1].
ACC is characteristic for its indolent nature and its pro-
pensity for late distant metastases. Previous studies have
shown CD117 to be positive in most ACC; however, no
study has focused on the relationship between expres-
sion, histological grade and prognosis.Methods and materials
From 2005 to 2012, a total of 125 ACC patients were
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reproduction in any medium, provided the orHospital. All samples were obtained after patients had
provided written, informed consent. Of these patients, 80
received substantial follow-ups between 3 to 216 months
after initial diagnosis. According to histological patterns,
tumors were divided into 4 grades: Grade 1 was tubular/
cribriform; Grade 2 was solid type of less than 30%; Grade
3 was solid type equal to or more than 31%; and Grade 4
showed high grade transformation. The patients were
divided into 2 stages. The early stage meant that the
cancer was limited to the organ in which it began, with-
out evidence of spreading. The advanced stage meant that
the cancer had spread beyond the primary site to lymph
nodes or nearby organs and tissues or distant organs.Immunohistochemical staining
CD117 (polyclonal rabbit; dilution 1:400; Dako, Carpin-
tera, CA, USA) and P63 (4A4; dilution 1:100; Dako,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Kaplan–Meier survival curves.
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sections by immunohistochemical staining. These were
performed on 4 μm thick unstained sections cut from
representative formalin-fixed paraffin-embedded blocks
by the avidin-biotin-peroxidase complex technique.
Statistical analysis
Statistical tests were performed using the SPSS software
package (12.0, Chicago, IL). Significances were assessed
with log-rank statistics, or using the chi-square test. The
cox proportional-hazards regression was used to analyze
the effect of several risk factors on survival.
Results
Patient characteristics are listed in Table 1. The study
population consisted of 38 males and 42 females.
Median age was 47.5 years (range, 8–81 years). The sub-
sites included the nasal cavity and paranasal sinuses
(n = 27), the lacrimal gland (n = 21) and other (n = 32).
The “other” category included the major salivary gland,
trachea, ear and tongue. All patients were classified as
grade 1 (67.5%, n = 54), grade 2 (15.0%, n = 12), grade 3
(12.5%, n = 10), or grade 4 (5.0%, n = 4). Seventy-six cases
were eventually divided into early stage (35%, n = 28)
and advanced stage (60%, n = 48). Four cases failed to
be classified due to lack of sufficient information. The 1-
year, 2-year, 5-year and 10-year rate of overall survival
was 88.89%, 79.77%, 66.41% and 10.16%, respectively
(Figure 1). Survival was not associated with primary sites
(P = 0.885), sex (P = 0.838), or age (P = 0.545). Twenty-






Lacrimal gland 21 (26.3)





Surrounding involvement 51 (63.4)
Nerve and vessel involvement 52 (65.0)
Histological grade
Grade 1 53 (66.3)
Grade 2 14 (17.5)
Grade 3 9 (11.3)
Grade 4 4 (5.0)metastasis predated the primary tumor. The latest was
detected 216 months after the initial diagnosis. Median
latency was 42.3 months. The most common sites for
metastases were lung (12), brain (9), and bone (6). Liver
(3) and skin (1) were also present. The following predic-
tors were analyzed as prognostic variables: sex, age,
recurrence, the site of metastasis, the subsite of initial
tumor, histological grade, surrounding involvement,
and nerve and vessel invasion. Only histological grade
was significantly associated with prognosis (P = 0.031).
Higher grade was related to poorer prognosis.
ACC consisted of 2 types of tumor cells. They were
p63-positive cells and p63-negative cells. CD117 was
positive in p63-negative cells in 94.3% of cases and was
not associated with the histological grade (P = 0.566) or
prognosis, regardless of being in the early or advanced
stage (Figure 2A and B). CD117, however, was positive
in p63-positive cells in 45.8% of cases. P63+/CD117+
cells were not associated with neither grade nor prog-
nosis in the early stage. They were, however, significantly
associated with grade (P<0.001) and prognosis (P = 0.037)
in the advanced stage (Figure 2C and D).Discussion
ACC is well-known for its indolent growth but common
recurrence and late distant metastasis. Although the 5-
year survival rate is high, 10-year and 15-year survival
markedly decreased. Hence, it is classified as “high risk”
by the World Health Organization [2]. The classic treat-
ment is complete resection followed by postsurgical
radiotherapy. In our study, 3 of 80 patients gave up sur-
gery on initial diagnosis and underwent radiotherapy
alone. The tumor developed gradually. The other 77
cases underwent surgery and postsurgical radiotherapy
but no chemotherapy. The 5-year and 10-year survival
was 66.41% and 10.16%, respectively, results which vary
greatly from some reported literature.
Figure 2 Immunostaining patterns for p63 and CD117. A and B, and C and D are 2 couples of serial sections, respectively. A and C
show immunostaining for p63. B and D show staining for CD117. Compared with A, B showed p63-/CD117+ cells (arrows). Compared with
C, D showed p63+/CD117+ cells (arrows).
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extremely low survival rate of ACC. Five-year and 10-
year survival rates of ACC in the salivary gland were
35% and 10%, respectively. Ten-year survival in the sino-
nasal subsite was 7%. The 10-year survival was similar to
that in our data, but the 5-year survival was much lower.
It was speculated that the cited data came from earlier
literature (1974, 1978, 1990), when both the treatment
and patient health care were different from today, which
eventually caused difference in 5-year survival [1,3,4].
However, ACC is characterized by endless growth and
late distant metastasis. It is radiosensitive but cannot be
cured by radiation alone. When surgery is unavailable
due to recurrence or metastasis, the outcome is poor.
This is why the 10-year survival rate was similarly low.
However, Ellington CL et al. has reported an extremely
high survival of ACC in 2012, with the 5-year, 10-year
and 15-year survival being 90%, 80% and 69%, respect-
ively [5]. Distant metastasis was detected in 11.57% of
cases. The data were based on a study of 3026 cases in
America between 1973 and 2003. In addition, Gomez
DR et al., in 2008, reported the 5-year and 10-year sur-
vival was 87% and 65%, respectively [6]. Distant metasta-
sis was detected in 34% of cases. The study was based
on 59 cases. The differences between their data and thepresent study were analyzed in terms of the following:
(1) the outcome for patients with ACC in the lacrimal
gland and sinonasal subsite was poorer than those with
ACC in the salivary gland. Although our study did not
reveal that survival was associated with the subsite, it
was reported that 5-year survival for patients with sino-
nasal ACC was from 50% to 62.9% [7,8]. Lacrimal gland
ACC and paranasal sinus ACC accounted for 60.0% in
our data, 42.4% in Gomez DR’s and 5.12% in Ellington
CL’s. More patients with lacrimal gland and sinonasal
ACC decreased our survival. (2) There were more
patients (60%) in advanced stage in our cohort, com-
pared with Ellington’s (47.95%) and Gomez’s (47.5%). (3)
Females had better survival outcomes, as concluded by
Ellington CL and Lloyd [9]. The male-to-female ratio
was 1:1.1 in our data, 1:1.9 in Gomez DR’s and 1:1.4 in
Ellington CL’s. Unfortunately, the relationship between
sex and survival was not confirmed in our study. (4)
None of our patients received chemotherapy, whereas
some patients of the other studies did, including cisplatin,
5-fluorouracil and anthracyclines. Although chemother-
apy showed inconsistent results, some patients did benefit
from it. (5) Higher grade related to poorer outcome.
17.6% of cases in our study were grade 3 or higher. The
other two studies did not list the histological grade;
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would eventually cause differences in outcomes. (6) All
patients in our study were Chinese. Asian and Pacific
Islanders accounted for only 7.77% in Ellington CL’s study
and none in Gomez DR’s. Race might play a role. (7) The
social and economic position should not be ignored in
medical behavior. Despite explanations for the differences,
further studies are required to confirm that a “high risk”
carcinoma can still have an excellent patient outcome.
CD117 (KIT) is a type III receptor tyrosine kinase
operating in cell signal transduction in several cell types.
KIT is activated by binding of its ligand, which leads to a
phosphorylation cascade ultimately activating various
transcription factors in different cell types. CD117 has
been detected in many normal cells and tumor cells
[10]. Previous studies have shown that 78% to 100% of
ACC expressed CD117 [10-15]. But only Mino M et al.
briefly discussed the relationship between the pattern of
immunostaining and the different histological subtypes.
Mino’s data were based on a cohort of 66 cases. The
data revealed that the solid subtype of ACC showed a
mostly diffuse pattern and the tubular and cribriform
subtypes demonstrated CD117 expression primarily
within the luminal epithelial cell layer, which was p63
negative. The authors, however, did not discuss CD117
expression in p63-positive cells.
Our study focused on the immunostaining patterns,
not only in p63-negative cells but also in p63-positive
cells, and compared the patterns with histology grades
and prognosis. Our study revealed that the P63-/CD117+
pattern was not associated with histological grade or
prognosis in either stage. Interestingly, the P63+/CD117+
pattern was not related to grade or prognosis in the early
stage. It was, however, significantly related to grade and
prognosis in the advanced stage. Increased numbers of
P63+/CD117+ cells meant a higher histological grade
and a poorer prognosis. The current theory was that
the organ stem cell with pluripotent differentiation
capability would unidirectionally differentiate toward
myoepithelia (p63-positive cells) or glandular epithelia
(p63-negative cells) in ACC. Since myoepithelia has cyto-
plastic smooth muscle fibril, and smooth muscle cells are
constantly negative for CD117, it is inferred that the
p63-positive/CD117-positive cells are tumor cells with
less differentiation toward myoepithelia. Once the differ-
entiation is extensively insignificant (meaning p63-
positive cells remarkably decrease or are absent), high
grade transformation will be present, which was once
called dedifferentiation.
Our study also revealed the different significance of
p63+/CD117+ cells in early stage and advanced stage,
respectively. In addition to the non-relationship between
stage and prognosis, it was thought that ACC in differ-
ent stages were heterogenous.Conclusion
Our study revealed differences in survival rates of ACC
between Chinese and occidental data, with more studies
expected to further explain the difference. This study
revealed the relationship between the patterns of CD117
expression and histological grades and prognosis in
the advanced stage. In addition to traditional histological
subtypes and novel p-AKT [15], the expression of
CD117 could help to assess prognosis.
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